samedan logo
home > ict > autumn 2020 > the colours of change
International Clinical Trials

The Colours of Change

Some time ago, a survey was conducted on clinical trial professionals to determine what concerns worried the industry most, experts from pharmaceutical company sponsors, contract research organisations, site representatives, and vendors were consulted. Despite all the great work by these collective groups, an overwhelming number of studies fail for the simple reason that not enough patients stick with them (1). A whopping 85% of studies, in fact, according to Forte Research (2).

Once the results were assessed, ranked fourth behind the likes of trial complexity, regulatory frameworks, and increasing costs, was patient recruitment and retention.

Then, early this year, in a moment of history we are unlikely to forget, COVID-19 hit. Suddenly hospitals and healthcare facilities the world over were sent into pandemic pandemonium, and as we scrabbled for solutions many non-essential clinical trials were put on hold and their patients left in limbo.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
Chris Wells is an accomplished travel specialist, event planner, creative thinker, and patient pioneer. Having spent years building programmes in the healthcare and technology sectors, Chris dedicates every minute of every day to better understand and eradicate the burden of clinical trial participation on patients and their families. As Director of Patient Concierge Services at Illingworth Research Group, their PatientGO division works tirelessly to ensure patients receive the optimum home-to-site experience. This helps to reduce study dropout, relieves the pressure on sites, and gives the medicines of the future a fighting chance of helping humanity’s most challenging and deadly diseases.

Print this page
Send to a friend
Privacy statement
News and Press Releases

How to Identify and Manage Risks in Clinical Trial Supplies and Comparator Sourcing: The Benefits of the Global Reach, Upcoming Webinar Hosted by Xtalks

Running a successful clinical trial relies heavily on the management of risks within the supply chain. Risk management is an essential part of clinical trials to ensure that sponsors can generate a clear return on investment without disruptions.
More info >>

White Papers

Running Smarter Trials With Data-Driven Monitoring


Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm.  Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement